LH vs STRO · P/E 23, rev $13.01B vs rev $62.0M
Laboratory Corporation of America Holdings (LH) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported LH revenue for 2024-12-31 was $13.01B. Net income was $747.1M. Revenue was up 7.0% from 2023-12-31 to 2024-12-31. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
LH currently screens at market cap $21.07B and trailing P/E 22.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the LH and STRO stock pages for the full models.
Not investment advice.